Pharmafoods Inc. Revises Earnings Forecast — Operating Profit Up 33%, Net Profit Up 50%
Pharmafoods Inc. (TSE:29290), a functional food and cosmetics company, has revised its FY2026 (July 2026) full-year earnings forecast upward.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 68,000M | JPY 67,000M | ▲JPY 1,000M (▲1.5%) |
| Operating Profit | JPY 1,500M | JPY 2,000M | +JPY 500M (+33.3%) |
| Ordinary Income | JPY 1,500M | JPY 2,000M | +JPY 500M (+33.3%) |
| Net Profit | JPY 1,000M | JPY 1,500M | +JPY 500M (+50.0%) |
| EPS | JPY 34.64 | JPY 51.65 | +JPY 17.01 (+49.1%) |
The revision follows strong performance in the mid-term period, driven by robust sales of its flagship brand “Newmo Series” and the successful launch of new products. These new offerings are becoming a key revenue driver, contributing to improved profitability. The company also noted enhanced capital efficiency across the group, which has boosted overall financial performance.
The upward revision reflects Pharmafoods Inc.’s improved profitability and commitment to strengthening its revenue-generating capabilities. Investors should view this as a sign of the company’s ongoing efforts to enhance financial performance and sustain growth.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.